Related Experiment Video
Updated: Jul 15, 2026

Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches
Published on: October 13, 2022
Bid is cleaved upstream of caspase-8 activation during TRAIL-mediated apoptosis in human osteosarcoma cells
Theodore O Garnett1, Maria Filippova, Penelope Jayne Duerksen-Hughes
1Department of Biochemistry and Microbiology, Loma Linda University School of Medicine, 11085 Campus Street, 121 Mortensen Hall, Loma Linda, CA, 92354, USA.
Abstract:
TRAIL induces apoptosis in many malignant cell types. In this study, we used the human papilloma virus (HPV) 16 E6 protein as a molecular tool to probe the TRAIL pathway in HCT116 colon carcinoma cells and U2OS osteosarcoma cells. Intriguingly, we found that while E6 protected HCT116 cells from TRAIL, U2OS cells expressing E6 remained sensitive to TRAIL. Furthermore, silencing FADD and procaspase-8 expression with siRNA did not prevent TRAIL-induced apoptosis in U2OS cells. However, siBid provided significant protection from TRAIL, and the cleavage kinetics of Bid and caspase-8 revealed that Bid was cleaved prior to the activation of caspase-8. Cathepsin B activity in U2OS cells was significantly activated shortly after exposure to TRAIL, and the cathepsin B inhibitor, CA074Me, inhibited both TRAIL- and anti-DR5-mediated apoptosis and delayed the cleavage of Bid. These findings suggest that TRAIL activates a pathway dependent on Bid, but largely independent of FADD and caspase-8, in U2OS cells.
Insights
Human papillomavirus (HPV) 16 E6 protein differentially affects TRAIL-induced apoptosis. In U2OS cells, TRAIL activates a pathway dependent on Bid, independent of FADD and caspase-8.
Area of Science:
- Cell biology
- Molecular biology
- Cancer research
Background:
- Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in cancer cells.
- The human papillomavirus (HPV) 16 E6 protein is studied for its role in cellular pathways.
Purpose of the Study:
- To investigate the role of HPV 16 E6 in TRAIL-induced apoptosis.
- To elucidate the molecular mechanisms of TRAIL signaling in HCT116 and U2OS cells.
Main Methods:
- Utilized HPV 16 E6 protein as a molecular probe.
- Employed small interfering RNA (siRNA) to silence FADD, procaspase-8, and Bid.
- Assessed apoptosis induction via TRAIL and anti-DR5 antibodies.
- Measured cathepsin B activity and inhibition using CA074Me.
Main Results:
- HPV 16 E6 protected HCT116 cells from TRAIL but not U2OS cells.
- TRAIL-induced apoptosis in E6-expressing U2OS cells was independent of FADD and caspase-8.
- Silencing Bid conferred protection from TRAIL, with Bid cleavage preceding caspase-8 activation.
- TRAIL activated cathepsin B, which was inhibited by CA074Me, affecting apoptosis and Bid cleavage.
Conclusions:
- TRAIL signaling in U2OS cells involves a Bid-dependent pathway.
- This pathway is largely independent of FADD and caspase-8.
- Cathepsin B plays a significant role in TRAIL-mediated apoptosis in these cells.
Related Concept Videos
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Apoptosis
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.

